[ad_1]
This week, the F.D.A. is likely to approve the first gene therapy for sickle cell disease, a painful, life-shortening illness that affects around 100,000 Americans, most of them Black.
Dr. Daniela Lamas, a Times Opinion contributing writer, argues that for too long the American health care system has failed sickle cell patients. In her reporting, Dr. Lamas spoke with Lynndrick Holmes, a sickle cell patient who underwent a trial of gene therapy. In this audio essay, they explain how the new treatment works and why it’s an opportunity for the medical community to finally do right by patients who historically have been overlooked.
(A full transcript of this audio essay will be available midday on the Times website.)
The Times is committed to publishing a diversity of letters to the editor. We’d like to hear what you think about this or any of our articles. Here are some tips. And here’s our email: letters@nytimes.com.
Follow the New York Times Opinion section on Facebook, X (@NYTOpinion) and Instagram.
This episode of “The Opinions” was produced by Jillian Weinberger. It was edited by Kaari Pitkin, Alison Bruzek and Annie-Rose Strasser. Mixing by Sonia Herrero. Original music by Sonia Herrero, Pat McCusker and Carole Sabouraud. Fact-checking by Mary Marge Locker. Audience strategy by Kristina Samulewski and Shannon Busta.
[ad_2]
Source link
